Fortress Biotech Inc. (FBIO) is primed for evolution with the beta value of 2.15

Let’s start up with the current stock price of Fortress Biotech Inc. (FBIO), which is $3.97 to be very precise. The Stock rose vividly during the last session to $4.45 after opening rate of $4.42 while the lowest price it went was recorded $3.93 before closing at $4.37.

Fortress Biotech Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $4.78 on 09/18/20, with the lowest value was $1.04 for the same time period, recorded on 03/16/20.

Fortress Biotech Inc. (FBIO) full year performance was 171.92%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Fortress Biotech Inc. shares are logging -16.95% during the 52-week period from high price, and 281.73% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $1.04 and $4.78.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1973949 for the day, which was evidently higher, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Fortress Biotech Inc. (FBIO) recorded performance in the market was 54.47%, having the revenues showcasing 36.90% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 328.24M, as it employees total of 93 workers.

The Analysts eye on Fortress Biotech Inc. (FBIO)

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 3.09, with a change in the price was noted +1.93. In a similar fashion, Fortress Biotech Inc. posted a movement of +94.61% for the period of last 100 days, recording 1,214,346 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for FBIO is recording 1.51 at the time of this writing. In addition, long term Debt to Equity ratio is set at 1.15.

Technical rundown of Fortress Biotech Inc. (FBIO)

Raw Stochastic average of Fortress Biotech Inc. in the period of last 50 days is set at 62.67%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 49.06%. In the last 20 days, the company’s Stochastic %K was 72.12% and its Stochastic %D was recorded 85.36%.

Considering, the past performance of Fortress Biotech Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 54.47%. Additionally, trading for the stock in the period of the last six months notably improved by 152.87%, alongside a boost of 171.92% for the period of the last 12 months. The shares increased approximately by -9.98% in the 7-day charts and went down by 15.74% in the period of the last 30 days. Common stock shares were driven by 36.90% during last recorded quarter.